Stem Cell Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 162 Agreements Signed Since 2016

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Collaboration and Licensing Deals 2016-2024" report has been added to * ResearchAndMarkets.com's* offering.

*Stem Cell Collaboration and Licensing Deals* provides a comprehensive understanding and unprecedented access to the stem cell deals entered into by the world's leading biopharma companies. Fully revised and updated, the report provides details of stem cell deals from 2016 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter stem cell deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 162 stem cell deals announced since 2016 including financial terms where available including links to online deal records of actual stem cell partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The report also includes numerous table and figures that illustrate the trends and activities in stem cell deal making since 2016. In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

*Key Benefits*

· Understand deal trends since 2016
· Browse stem cell collaboration and licensing deals
· Benchmark analysis - identify market value of transactions
· Financials terms - upfront, milestone, royalties
· Directory of deals by company A-Z, deal type and therapy area
· Leading deals by value
· Most active dealmakers
· Identify assets and deal terms for each transaction
· Access contract documents - insights into deal structures
· Due diligence - assess suitability of your proposed deal terms for partner companies
· Save hundreds of hours of research time

*Analyzing contract agreements allows due diligence of:*

· What are the precise rights granted or optioned?
· What is actually granted by the agreement to the partner company?
· What exclusivity is granted?
· What is the payment structure for the deal?
· How are sales and payments audited?
· What is the deal term?
· How are the key terms of the agreement defined?
· How are IPRs handled and owned?
· Who is responsible for commercialization?
· Who is responsible for development, supply, and manufacture?
· How is confidentiality and publication managed?
· How are disputes to be resolved?
· Under what conditions can the deal be terminated?
· What happens when there is a change of ownership?
· What sublicensing and subcontracting provisions have been agreed?
· Which boilerplate clauses does the company insist upon?
· Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
· Which jurisdiction does the company insist upon for agreement law?

*Key Topics Covered:*

*Chapter 1 - Introduction*

*Chapter 2 - Trends in stem cell dealmaking*
2.1. Introduction
2.2. Stem cell deals over the years
2.3. Most active stem cell dealmakers
2.4. Stem cell deals by deal type
2.5. Stem cell deals by therapy area
2.6. Stem cell deals by industry sector
2.7. Deal terms for stem cell deals
2.7.1 Stem cell deals headline values
2.7.2 Stem cell deal upfront payments
2.7.3 Stem cell deal milestone payments
2.7.4 Stem cell royalty rates

*Chapter 3 - Leading stem cell deals*
3.1. Introduction
3.2. Top stem cell deals by value

*Chapter 4 - Most active stem cell dealmakers*
4.1. Introduction
4.2. Most active stem cell dealmakers
4.3. Most active stem cell deals company profiles

*Chapter 5 - Stem cell contracts dealmaking directory*
5.1. Introduction
5.2. Stem cell contracts dealmaking directory

*Chapter 6 - Stem cell dealmaking by technology type*

*Deal directory*

· Deal directory - Stem cell deals by company A-Z
· Deal directory - Stem cell deals by deal type
· Deal directory - Stem cell deals by therapy area
· Deal type definitions

*Companies Featured*

· A*STAR Agency for Science
· Technology and Research
· A*STAR Genome Institute of Singapore
· Abu Dhabi Stem Cells Center
· Accellta
· Actinium Pharmaceuticals
· AGC Asahi Glass
· Ageless Biotech
· AgeX Therapeutics
· AiVita Biomedical
· Akadeum Life Sciences
· Alkem Laboratories
· Allele Biotechnology and Pharmaceuticals
· American Society of Hematology
· American Type Culture Collection (ATCC)
· Amgen
· Angiostem
· Anthony Nolan
· Apceth
· Arbor Biotechnologies
· Ascendance Biotechnology
· Astellas Pharma
· AstraZeneca
· Athersys
· Australian Research Council
· Axcelead Drug Discovery Partners
· Axiogenesis
· AxoSim
· Barbara Ann Karmanos Cancer Institute
· Be The Match BioTherapies
· Bio-Techne
· BioCardia
· BioEclipse Therapeutics
· BiolineRX
· Biological Industries
· Biomed
· bioRASI
· BlueRock Therapeutics
· Boehringer Ingelheim
· Bone Therapeutics
· BrainStorm Cell Therapeutics
· Brigham and Women's Hospital
· Bristol-Myers Squibb
· Calidi Biotherapeutics
· California Institute for Regenerative Medicine
· Calimmune
· Cell2in
· Cell Care Therapeutics
· Cellect Biotechnology
· Cellectricon
· Celling Biosciences
· CellProThera
· Celltex Therapeutics
· Cellular Biomedicine
· Cellular Dynamics International
· Censo Biotechnologies
· Centogene
· Centre for Drug Research and Development (CDRD)
· Children's Hospital Boston
· China Southeast University
· Cincinnati Children's Hospital Medical Center
· Cipla
· Citius Pharmaceuticals
· Cognate BioServices
· Columbia University
· Creative Medical Technologies
· CRISPR Therapeutics
· Crown Bioscience
· Cynata Therapeutics
· CytoMed Therapeutics
· CYTOVIA Therapeutics
· Deepcell
· DefiniGEN
· Department of Defense
· DePuy
· EdiGene
· Elixirgen
· ERS Genomics
· Eterna Therapeutics
· Ethos Discovery
· Eutilogics
· Evotec
· ExCellThera
· Exploit Technologies
· Florica Therapeutics
· Fondazione San Raffaele
· Fondazione Telethon
· Food and Drug Administration (FDA)
· Fraunhofer Institute for Molecular Ecology (IME)
· Fujifilm
· FUJIFILM Cellular Dynamics
· Gallant Therapeutics
· Gamida Cell
· GE Healthcare
· Genezen
· Golden Meditech
· GSK
· Hadassah Medical Center
· Haihe Laboratory of Cell Ecosystem
· Hamad Bin Khalifa University
· Harvard Stem Cell Institute
· Harvard University
· Healios K.K.
· Heartseed
· Hemostemix
· Histogen
· Hong Kong Baptist University
· Huapont Pharma
· Human Life CORD Japan
· Immunis
· ImmunityBio
· ImmunoCellular Therapeutics
· Implant Therapeutics
· Indiana University
· Insitro
· Instem
· Institute Of Molecular Biotechnology
· InVivo Therapeutics
· Israeli National Authority for Technological Innovation
· Jadi Cell
· Janssen Biotech
· Jasper Therapeutics
· JCR Pharmaceuticals
· Johns Hopkins University
· Johnson & Johnson Innovation
· Keck School of Medicine of USC
· Kings College London
· Kite Pharma
· Kumamoto University
· Kyoto University
· Leiden University
· Leona M and Harry B Helmsley Charitable Trust
· Lineage Cell Therapeutics
· Longeveron
· Lupus Foundation of America (LFA)
· Macquarie University
· Magenta Therapeutics
· Maryland Stem Cell Research Fund
· Maryland Technology Development Corporation
· Maxcyte
· McGill University
· Medac
· Medexus Pharmaceuticals
· Memorial Sloan Kettering Cancer Center
· Merck and Co
· Mesoblast
· Metrion Biosciences
· Michael J Fox Foundation
· Molecular Templates
· Multiclonal Therapeutics
· Murdoch Childrens Research Institute
· myTomorrows
· NanoCellect Biomedica
· Nano Dimension
· NantKwest
· Nanyang Technological University
· National Cancer Institute
· National Heart
· Lung and Blood Institute
· National Institute of Allergy and Infectious Diseases
· National Institute on Aging
· National Institutes of Health
· National Science Foundation
· National University of Ireland
· Galway (NUI Galway)
· Ncardia
· Northwestern University
· Novellus Therapeutics
· Novo Nordisk
· Nvidia
· Ocumension Therapeutics
· Omeros
· OncoImmune
· Orchard Therapeutics
· Organovo
· ORIG3N
· Orthocell
· Pathways to Stem Cell Science
· Plasticell
· Platelet BioGenesis
· Pluristem Therapeutics
· Pluristyx
· PreCerv
· Procella Therapeutics
· Procyon Technologies
· Pulthera
· Q Therapeutics
· Regeneus
· ReNeuron
· Renovacare
· Research Products Development Company
· Royal Children's Hospital
· Rubedo Life Sciences
· RxBio
· Salk Institute
· Sana Biotechnology
· SanBio
· Scaled Biolabs
· SCM Pharma
· Seattle Childrens Research Institute
· Seres Therapeutics
· Shanghai Cell Therapy Group
· Sharp Edge Labs
· Shoreline Biosciences
· SimonMed Imaging
· Sirion Biotech
· Smartwise
· Spinogenix
· Stanford University
· StemCardia
· Stemcell Technologies
· Stemedica Cell Technologies
· Stem Genomics
· Stempeutics
· TaiRx
· Takeda Pharmaceutical
· Technology University Dresden
· Teijin
· Terumo Blood and Cell Technologies
· The New York Stem Cell Foundation
· Therakine
· Therapeutic Solutions International
· The Regents of the University of California
· Thrive Bioscience
· TiGenix
· Tissue Genesis
· TONIX Pharmaceuticals
· Trestle Biotherapeutics
· Trillium Therapeutics
· Tu Dresden
· U CAN-CER VIVE Foundation
· University Ann & Robert H. Lurie Children's Hospital
· University Health Network
· University of Adelaide
· University of California
· University of California Irvine
· University of California Los Angeles
· University of California San Francisco
· University of Maryland
· University of Pittsburgh
· University of Queensland
· University of Southern California
· University of Tokyo
· University of Washington
· Vascugen
· Vertex Pharmaceuticals
· ViaCyte
· VistaGen Therapeutics
· Vivo Biosciences
· Vor Biopharma
· WCTE
· W L Gore
· Yumanity Therapeutics

For more information about this report visit https://www.researchandmarkets.com/r/9ktpbh

*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900